AG009CM3

1338247-35-0 | N-(5-(1-(2,6-Dichlorophenyl)-3-(difluoromethyl)-1H-pyrazol-5-yl)thiazol-2-yl)isobutyramide

Chemical structure of N-(5-(1-(2,6-Dichlorophenyl)-3-(difluoromethyl)-1H-pyrazol-5-yl)thiazol-2-yl)isobutyramide, CAS 1338247-35-0
AG009CM3
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 1338247-35-0
Catalog Number AG009CM3(AGN-PC-0WGD3B)
Chemical Name N-(5-(1-(2,6-Dichlorophenyl)-3-(difluoromethyl)-1H-pyrazol-5-yl)thiazol-2-yl)isobutyramide
IUPAC Name N-[5-[2-(2,6-dichlorophenyl)-5-(difluoromethyl)pyrazol-3-yl]-1,3-thiazol-2-yl]-2-methylpropanamide
InChI InChI=1S/C17H14Cl2F2N4OS/c1-8(2)16(26)23-17-22-7-13(27-17)12-6-11(15(20)21)24-25(12)14-9(18)4-3-5-10(14)19/h3-8,15H,1-2H3,(H,22,23,26)
InChI Key IVUGBSGLHRJSSP-UHFFFAOYSA-N
MDL Number MFCD17019327
Molecular Formula C17H14Cl2F2N4OS
Molecular Weight 431.2871
SMILES CC(C)C(=O)Nc1ncc(s1)c2cc(nn2c3c(cccc3Cl)Cl)C(F)F
Synonyms
BMS-5, 1338247-35-0, LIMKi 3, BMS 5, N-(5-(1-(2,6-dichlorophenyl)-3-(difluoromethyl)-1H-pyrazol-5-yl)thiazol-2-yl)isobutyramide, N-[5-[2-(2,6-dichlorophenyl)-5-(difluoromethyl)pyrazol-3-yl]-1,3-thiazol-2-yl]-2-methylpropanamide, N-[5-[1-(2,6-Dichlorophenyl)-3-(difluoromethyl)-1H-pyrazol-5-yl]-2-thiazolyl]-2-methylpropanamide, N-{5-[1-(2,6-dichlorophenyl)-3-(difluoromethyl)-1H-pyrazol-5-yl]-1,3-thiazol-2-yl}-2-methylpropanamide, LIMKi3, LIM Kinase Inhibitor I, C17H14Cl2F2N4OS, GTPL9839, CHEMBL2141887, SCHEMBL15543888, EX-A934, SYN1024, CHEBI:138670, HMS3244I07, HMS3244I08, HMS3244J07, BCP17223, MFCD17019327, RS0051, ZINC72232826, AKOS024458322, CS-5617, NCGC00263197-01, NCGC00263197-03, AK547236, AS-16195, HY-18305, B7707, FT-0700442, J-523083, BMS3, A12839, 745053-65-0,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited